Aflac stock: BofA cuts target from USD 137 to USD 133 for Aflac stock

Published on 10/23/2026 at 15:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aflac releases third-quarter results on November 4, 2026. Aflac stock costs EUR 109.85 at Lang & Schwarz on October 23, 2026.

Analyst target cut

Bank of America cut its Aflac target from USD 137.00 to USD 133.00 on October 12, 2026.
Aflac will release third-quarter results on November 4, 2026.
Aflac stock costs EUR 109.85 at Lang & Schwarz on October 23, 2026 at 3:31 p.m. CEST.

Architektur-Render: Moderner Versicherungscampus mit Glasbauten — AFLAC Inc. modern corporate insurance campus architectural visualization render, ISIN US0010551028 headquarters, Illustration mit AI erstellt.

AFLAC Inc. (ISIN US0010551028) is heading toward a lower analyst target after Bank of America cut its price objective from USD 137.00 to USD 133.00 on October 12, 2026, while keeping a Buy rating, as reported by Markets Insider. The stock was trading at EUR 109.85 at Lang & Schwarz on October 23, 2026 at 3:31 p.m. CEST.

Bank of America lowers the target

The revised USD 133.00 objective stands 8.24 percent above the NYSE quote of USD 122.88 on October 23, 2026 at 9:36 a.m. ET. The analyst note also retained a Buy rating and linked its estimates to catastrophe losses at or slightly below long-term trends, according to Markets Insider.

November 4 is the next date

Aflac will release its third-quarter 2026 financial results after the market closes on November 4, 2026, followed by a webcast at 8:00 a.m. ET on November 5, 2026. The company announced the schedule in a September 30, 2026 release carried on its investor-relations site, Aflac. The webcast will include Chief Executive Officer Daniel P. Amos and Chief Financial Officer Max K. Broden.

What does the latest quarter add?

For the second quarter of 2026, Aflac reported USD 4.22 billion in revenue and USD 1.75 in adjusted earnings per share on August 6, 2026. Revenue was down 1.00 percent from the prior-year quarter, while earnings per share missed the USD 1.76 consensus by USD 0.01, according to MarketBeat. That combination makes the November release important for judging whether the earnings shortfall was temporary.

Price position and valuation

On the NYSE, Aflac was last at USD 122.88 on October 23, 2026 at 9:36 a.m. ET. The quote stood 5.63 percent below its USD 130.22 52-week high and 16.53 percent above its USD 105.43 52-week low. Market capitalization was USD 61.6 billion, the price-to-earnings ratio was 13.27, and the dividend yield was 2.00 percent as of October 23, 2026.

Stock stays tied to the target

The USD 133.00 target leaves a measurable gap above the NYSE quote, but the next company result remains the nearer date for investors tracking earnings execution. Aflac operates supplemental health and life insurance businesses in the United States and Japan.

The further course of trading is shown by the continuously updated real-time quote of Aflac stock.